Type D lymphomatoid papulosis associated with chemotherapy/chemoradiotherapy-induced severe chronic lymphocytopenia

J Dermatol. 2019 Nov;46(11):e412-e414. doi: 10.1111/1346-8138.15019. Epub 2019 Jul 25.

Authors

Youhei Uchida¹, Aoi Okubo¹, Maiko Hayashida², Hirosaka Inoue², Hiroko Tamura³, Kazuyasu Fujii¹, Kenji Ishitsuka², Takuro Kanekura¹

Affiliations

¹ Departments of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
² Hematology and Immunology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
³ Pulmonary Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

PMID: 31342531
DOI: 10.1111/1346-8138.15019

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Biopsy
Buttocks
Carcinoma, Neuroendocrine / diagnosis
Carcinoma, Neuroendocrine / radiotherapy*
Chemoradiotherapy / adverse effects
Chemoradiotherapy / methods
Diagnosis, Differential
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / radiotherapy*
Lymphoma, B-Cell, Marginal Zone / drug therapy*
Lymphoma, B-Cell, Marginal Zone / pathology
Lymphomatoid Papulosis / diagnosis
Lymphomatoid Papulosis / etiology*
Lymphomatoid Papulosis / pathology
Lymphopenia / blood
Lymphopenia / diagnosis
Lymphopenia / etiology*
Male
Middle Aged
Severity of Illness Index
Skin / pathology
Skin Neoplasms / diagnosis
Skin Neoplasms / etiology*
Skin Neoplasms / pathology